Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A synthetic retinoic acid receptor γ antagonist (7C)-loaded nanoparticle enhances bone morphogenetic protein-induced bone regeneration in a rat spinal fusion model

The Spine Journal(2023)10.1016/j.spinee.2023.11.021Source: DataRank Database

A synthetic retinoic acid receptor γ antagonist (7C)-loaded nanoparticle enhances bone morphogenetic protein-induced bone regeneration in a rat spinal fusion model is a research paper published in The Spine Journal (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.16)OA: greenTopics (49)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Masahiro Iwamoto,Joe Kodama ORCID,Yuichiro Ukon ORCID,Hiromasa Hirai ORCID,Masato Ikuta ORCID

Live enrichment

PubMed:38092193 OpenAlex:https://openalex.org/W4389580745

Japan Society for the Promotion of Science

Grant: 20K09479

Japan Orthopaedics and Traumatology Foundation

Grant: 484

National Institutes of Health

Grant: AR056837

National Institutes of Health

Grant: AR072713

NIAMS NIH HHS

Grant: R01 AR056837

NIAMS NIH HHS

Grant: R01 AR072713

FWCI

0.16

Citation Percentile

0.4%

Citation Trend

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11610515

publisherhttps://api.elsevier.com/content/article/PII:S1529943023035398?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1529943023035398?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.spinee.2023.11.021

Fields of Study

Bone Tissue Engineering MaterialsGraphene and Nanomaterials ApplicationsTGF-β signaling in diseasesAnimalsMaleRatsBone Morphogenetic Protein 2Bone RegenerationNanoparticlesRats, Sprague-DawleyReceptors, Retinoic AcidRecombinant ProteinsRetinoic Acid Receptor gammaSpinal FusionTransforming Growth Factor beta

MeSH Terms

Retinoic Acid Receptor gammaAnimalsBone RegenerationMaleRecombinant ProteinsSpinal FusionTransforming Growth Factor betaRats, Sprague-DawleyReceptors, Retinoic AcidRatsNanoparticlesBone Morphogenetic Protein 2

Keywords

MedicineBone morphogenetic proteinRetinoic acidBone morphogenetic protein 2AntagonistSpinal fusionRegeneration (biology)Cell biologyPharmacologyReceptorInternal medicineSurgeryBiochemistryCell cultureBiologyGeneticsIn vitroBMP/Smad signalingBone regenerationEndochondral bone formationRARγ inverse agonistRetinoic acid receptor γ